Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karissa Gable

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Continuum (Minneapolis, Minn.)|October 18, 2023
Chronic Immune-Mediated Demyelinating NeuropathiesKarissa Gable
Muscle & Nerve|May 27, 2016
Ultrasound in EMG-Guided Biopsies: A Prospective, Randomized Pilot TrialSantoshi Billakota, Carolina Dejesus-Acosta, Karissa Gable, et al.
Neuroepidemiology|January 12, 2026
Incidence, Prevalence, and Treatment Patterns in Chronic Inflammatory Demyelinating Polyneuropathy: Data Analysis of United States ClaimsKarissa Gable, Joel Arackal, Yuriy Edwards, et al.
Breast Cancer Research and Treatment|September 6, 2005
Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cellsJack F Youngren, Karissa Gable, Cristina Penaranda, et al.
Experimental Neurology|December 16, 2019
Inhibition of the transcription factor ROR-γ reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravisJohn S Yi, Melissa A Russo, Shruti Raja, et al.
Frontiers in Neurology|February 28, 2017
B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease SeverityJohn S Yi, Melissa A Russo, Janice M Massey, et al.
Journal of Cellular Biochemistry|May 9, 2007
Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cellsGary E Meyer, Louis Chesler, Dandan Liu, et al.
Neurology. Education|October 3, 2024
The Neuromuscular Portal and Match: Working Toward a More Fair, Equitable, and Transparent ProcessRuple S Laughlin, Shirlyn Adkins, Michael Baer, et al.
Muscle & Nerve|November 25, 2015
Construction and validation of the chronic acquired polyneuropathy patient-reported index (CAP-PRI): A disease-specific, health-related quality-of-life instrumentKelly G Gwathmey, Mark R Conaway, Reza Sadjadi, et al.
Neurology|June 16, 2026
Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating PolyradiculoneuropathyJeffrey A Allen, Filip Eftimov, Luis Querol, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Continuum (Minneapolis, Minn.)|October 18, 2023
Chronic Immune-Mediated Demyelinating NeuropathiesKarissa Gable
Muscle & Nerve|May 27, 2016
Ultrasound in EMG-Guided Biopsies: A Prospective, Randomized Pilot TrialSantoshi Billakota, Carolina Dejesus-Acosta, Karissa Gable, et al.
Neuroepidemiology|January 12, 2026
Incidence, Prevalence, and Treatment Patterns in Chronic Inflammatory Demyelinating Polyneuropathy: Data Analysis of United States ClaimsKarissa Gable, Joel Arackal, Yuriy Edwards, et al.
Breast Cancer Research and Treatment|September 6, 2005
Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cellsJack F Youngren, Karissa Gable, Cristina Penaranda, et al.
Experimental Neurology|December 16, 2019
Inhibition of the transcription factor ROR-γ reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravisJohn S Yi, Melissa A Russo, Shruti Raja, et al.
Frontiers in Neurology|February 28, 2017
B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease SeverityJohn S Yi, Melissa A Russo, Janice M Massey, et al.
Journal of Cellular Biochemistry|May 9, 2007
Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cellsGary E Meyer, Louis Chesler, Dandan Liu, et al.
Neurology. Education|October 3, 2024
The Neuromuscular Portal and Match: Working Toward a More Fair, Equitable, and Transparent ProcessRuple S Laughlin, Shirlyn Adkins, Michael Baer, et al.
Muscle & Nerve|November 25, 2015
Construction and validation of the chronic acquired polyneuropathy patient-reported index (CAP-PRI): A disease-specific, health-related quality-of-life instrumentKelly G Gwathmey, Mark R Conaway, Reza Sadjadi, et al.
Neurology|June 16, 2026
Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating PolyradiculoneuropathyJeffrey A Allen, Filip Eftimov, Luis Querol, et al.
Pageof 2